Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Royalty semantics

Royalty semantics

posted on Oct 06, 2009 01:45PM

CUPERTINO, Calif. – October 5, 2009 – Alliacense announced today a wave of new MMP™ Portfolio licensees less than three weeks after the USPTO announced it's decision to affirm the validity of US’336, the most widely recognized patent in the MMP Portfolio. The new licensees include Harman International, TPV Technology, and Textron Inc., and will result in both upfront and future payments, as the increasing rates of the MMP Licensing Program has made onetime, lump-sum licenses too expensive for some companies

http://www.alliacense.com/Press_Release_Details.aspx?PressID=117

From the above statement, I see no reason to believe there is anything other than an agreed license fee for both past and future use.

Because of "the increasing rates of the MMP Licensing Program" it is my very humble opinion that a fee was agreed but that fee has been split into "upfront and future payments" on the basis that "onetime, lump-sum licenses (are) too expensive for some companies"

Obviously, there will be those that will make the full payment on licensing.

Corrections more than welcome.

.

.

Be well

PS Now that I know where Bartender sources his products, I'm going to demand discounted prices on the cocktails.

Share
New Message
Please login to post a reply